Aptamer Group PLC operates as a biotechnology company. The Company focuses on the development of aptamer technologies and develops nucleic acid aptamers for use in research and development, biomarker discovery, diagnostics, and therapeutic developments. Aptamer Group serves customers in the United Kingdom.

Results of 2025 Annual General Meeting

AGM Statement

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Aptamer Group (APTA LN)

Results of 2025 Annual General Meeting

AGM Statement

Strong contract wins build commercial momentum

New contract with top five pharma company

Posting of Annual Report and Notice of AGM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)